SGMO Latest Press Releases

-- December 18, 2025 --

Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease Globe Newswire 8:05 AM

-- December 2, 2025 --

Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy Globe Newswire 8:05 AM

-- November 21, 2025 --

Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease Globe Newswire 8:05 AM

-- October 30, 2025 --

Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call Globe Newswire 4:01 PM

-- September 4, 2025 --

Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025 Globe Newswire 8:05 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software